Life After STroke - the LAST Study (LAST)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01467206 |
Recruitment Status :
Completed
First Posted : November 8, 2011
Last Update Posted : April 13, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Cerebral Infarction Cerebral Hemorrhage | Behavioral: Long term follow up by a coordinating physiotherapist Behavioral: Standard care | Not Applicable |
Supplement to the Life After Stroke - the LAST study ClinicalTrials.gov ID: NCT01467206
Changes in the planned statistical analysis, November 9, 2015 The original plan for statistical analysis was published in; Askim T, Langhammer B, Ihle-Hansen H, Magnussen J, Engstad T, Indredavik B. A Long-Term Follow-Up Programme for Maintenance of Motor Function after Stroke: Protocol of the life after Stroke-The LAST Study. Stroke Res Treat. 2012;2012:392101. doi: 10.1155/2012/392101. Epub 2012 Nov 22.
Original plan for statistical analysis Reporting will follow the CONSORT statement for parallel group randomized trials [40]. Descriptive statistics will be performed in order to present the population and the characteristic of the two groups. All analyses will be analysed as intention-to-treat analysis according to the CONSORT instructions. Analysis of covariance (ANCOVA) will be used to study differences between groups according to the primary endpoint, motor assessment scale at 18 months after inclusion. The ANCOVA model will include stroke severity, age, pre stroke disability, treatment group, and motor function at baseline as covariates. Mann-Whitney U test will be used for secondary data not being normal distributed. In all analyses we will control for potential confounding factors, investigate effect modifications, and present both unadjusted and adjusted effects with 95% confidence intervals.
Subanalysis will be performed according to the stratification variables (stroke severity, age above 80 and recruitment site) to explore trends within subgroups of patients.
Revised plan for statistical analysis Reporting will follow the CONSORT statement for parallel group randomized trials [40]. Descriptive statistics will be performed in order to present the population and the characteristic of the two groups. All analyses will be analysed as intention-to-treat analysis according to the CONSORT instructions. Analysis of covariance (ANCOVA) will be used to study differences between groups according to the primary endpoint, motor assessment scale at 18 months after inclusion. The ANCOVA model will include stroke severity, age, pre stroke disability, treatment group, and motor function at baseline as covariates. Similar ANCOVA analyses will be used for the relevant secondary endpoints. Mann-Whitney U test will be used for secondary data not being normal distributed.
Subanalysis will be performed according to the stratification variables (stroke severity, age above 80 and recruitment site), gender, and cognitive status (Mini Mental State below 25), to explore trends within subgroups of patients.
Missing values will be handled using single imputation (typically for items on instrument scales), or by multiple imputation, as appropriate.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 380 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Life After STroke - the LAST Study. A Norwegian Multi Centre Randomized Controlled Trial |
Actual Study Start Date : | November 2011 |
Actual Primary Completion Date : | December 2015 |
Actual Study Completion Date : | December 2015 |

Arm | Intervention/treatment |
---|---|
Experimental: Long term follow up program |
Behavioral: Long term follow up by a coordinating physiotherapist
Monthly meetings with an coordinating physiotherapist who motivate and encourage the patient to do 60 minutes of weekly exercise and 30 minutes of daily physical activity |
Active Comparator: Standard care |
Behavioral: Standard care
Standard care as it is given to all stoke patients after stroke |
- Motor Assessment Scale [ Time Frame: 18 months after inclusion ]A measure of over all motor function
- Barthel Index [ Time Frame: 18 months follow up ]A measure of activities of daily living
- Modified Rankin Scale [ Time Frame: 18 months follow up ]A measure of dependency/independency
- Berg Balance Scale [ Time Frame: 18 months follow up ]A measure of balance related to basic movement tasks
- Timed Up and Go [ Time Frame: 18 months follow up ]A measure of balance related to transfer and walking
- Sit to stand test [ Time Frame: 18 months follow up ]A measure of dynamic muscle strength according to a sit to stand task
- Six minute walk test [ Time Frame: 18 months follow up ]A measure of endurance
- Stroke Impact Scale [ Time Frame: 18 months follow up ]A measure of health related quality of life after stroke
- EuroQol 5D [ Time Frame: 18 months follow up ]A simple measure of health related quality of life for the general population
- Fatigue Severity Scale [ Time Frame: 18 months follow up ]A measure of the presence of fatigue
- One simple question on fatigue from the HUNT3 questionnaire [ Time Frame: 18 months follow up ]A simple question used to assess tiredness in teh general Norwegian population
- Hospital Anxiety and Depression Scale [ Time Frame: 18 months follow up ]A measure of anxiety and depression
- Mini Mental State Examination [ Time Frame: 18 months follow up ]A measure of cognitive function
- Montreal Cognitive Assessment [ Time Frame: 18 months follow up ]A measure of cognitive function related to vascular dementia
- falls [ Time Frame: 6, 12 and 18 months ]Serious falls will be recorded from the patients hospital records
- Readmission to hospital [ Time Frame: 6, 12 and 18 months ]Number of readmissions to hospital will be recorded from the patients medical records
- Death [ Time Frame: 6, 12 and 18 months ]Information about death will be collected from the Norwegain Death Registry
- Fractures [ Time Frame: 6, 12 and 18 months ]Information about fractures during follow up will be collected from the patients medical records
- Cardiovascular events [ Time Frame: 6, 12 and 18 months ]Information about any cardiovascular events will be collected from the patients medical record
- Cerebrovascular events [ Time Frame: 6, 12 and 18 months ]Information about any cerebrovascular events during follow up will be collected from teh patient's medical records
- International Physical Activity Questionnaire [ Time Frame: 6, 12 and 18 months ]A measure of physical activity over the last week
- Physical activity assessed by ActivPAL sensor system [ Time Frame: 6, 12 and 18 months ]A sensor system to assess the amount of physical activity during a 4-7 day period
- Three simple questions on physical activity from the HUNT questionnaire [ Time Frame: 18 months ]A simple measure of physical activity
- Health costs [ Time Frame: 6, 12 and 18 months ]Information about the use of health services will be collected by reviewing the patients' hospital records and records in primary health care system.
- National Institutes of Health Stroke Scale [ Time Frame: 18 months follow up ]A measure of stroke severity
- Modified Ashworth Scale [ Time Frame: 18 months follow up ]A measure to rate the degree of spasticity after stroke
- Gait speed [ Time Frame: 18 months follow up ]A simple measure of maximum gait speed across a 10 metres distance
- Trailmaking test A and B [ Time Frame: 18 months follow up ]A simple measure of executive cognitive function
- DS-14 [ Time Frame: 18 months follow up ]A standard assessment of negative affectivity, social inhibition, and type D personality, which might be related to poor cardiovascular prognosis.
- VO2-peak [ Time Frame: 18 months follow up ]
VO2-peak is obtained by use of a symptom limited treadmill test to measure cardiovascular fitness.
This measure is only used in the Trondheim arm of the study

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 95 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Diagnosis of stroke according to WHO's definition of stroke
- Living in the city of Trondheim or the municipalities of Asker or Bærum
- Included 2.5 - 4 months after stroke
- Modified Rankin Scale 0 - 4
- Living at home
- Mini Mental State Examination > 20 or > 16 if aphasia
- Provide informed consent
Exclusion Criteria:
- Are already included in the study
- Are included in other experimental studies
- Unstable coronary function
- Uncompensated heartfailure
- Other diseases that make it difficult to complete the intervention

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01467206
Norway | |
Bærum Hospital | |
Sandvika, Norway | |
St. Olavs Hospital | |
Trondheim, Norway |
Study Director: | Bent Indredavik, Prof | National Taiwan Normal University | |
Principal Investigator: | Torunn Askim, PhD | National Taiwan Normal University |
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Norwegian University of Science and Technology |
ClinicalTrials.gov Identifier: | NCT01467206 |
Other Study ID Numbers: |
205309/H10 |
First Posted: | November 8, 2011 Key Record Dates |
Last Update Posted: | April 13, 2020 |
Last Verified: | April 2020 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Stroke Physiotherapy Motor training Rehabilitation |
Cerebral Infarction Cerebral Hemorrhage Infarction Hemorrhage Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Vascular Diseases Cardiovascular Diseases Ischemia Pathologic Processes Necrosis Brain Infarction Brain Ischemia Intracranial Hemorrhages |